Skip to content

Dalteparin Sodium

Published: July 26, 2026Updated: August 27, 2026

Dalteparin Sodium is a low molecular weight heparin (LMWH) anticoagulant used to prevent and treat blood clots. It works by enhancing the activity of antithrombin III, a natural protein that inhibits clotting factors in the blood. This medication is commonly administered via subcutaneous injection in hospital and outpatient settings.

Quick summary

Dalteparin Sodium is an injectable anticoagulant used to prevent and treat blood clots by enhancing natural anticoagulant pathways in the blood.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 27, 2026Editorial policy

Key facts at a glance

RxNorm
82137
Generic
Dalteparin Sodium
Class
pin-variant
Brands
Fragmin
Availability
rx
Lactation
unknown
Routes
—
Forms
—
Regions
US, EU, CN, JP
Monitoring
—

This page is for informational purposes only.

Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.

Prevention of venous thromboembolic events (VTE) in patients undergoing surgery, particularly orthopedic procedures; treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE); prevention of clotting in patients with reduced mobility; used in certain cancer patients to prevent thromboembolic complications.

Dalteparin enhances the activity of antithrombin III, a natural inhibitor of clotting factors (primarily factor Xa and to a lesser extent factor IIa/thrombin). This increases the blood's ability to prevent existing clots from growing and reduces the risk of new clots forming.

Administered by subcutaneous injection; requires careful monitoring in patients with renal impairment, low platelet counts, or history of heparin-induced thrombocytopenia (HIT); may increase bleeding risk; dose adjustments may be needed in elderly or underweight patients; regular monitoring of anti-Xa levels may be required in certain clinical situations.

Official drug label

WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 27, 2026. · Read our editorial policy